Inotiv, Inc. (NOTVQ)

Market Cap	1.57M -98.4%
Revenue (ttm)	507.36M +5.6%
Net Income	-86.97M
EPS	-2.53
Shares Out	34.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,955,431
Open	0.0540
Previous Close	0.0500
Day's Range	0.0345 - 0.0540
52-Week Range	0.0260 - 2.5700
Beta	3.77
Analysts	Strong Buy
Price Target	5.00 (+10,986.48%)
Earnings Date	n/a

About Inotiv

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the ...

• Industry: Commercial Physical and Biological Research
• Founded: 1974
• Employees: 2,046
• Stock Exchange: OTCMKTS
• Ticker Symbol: NOTVQ

Financial Performance

In fiscal year 2025, Inotiv's revenue was $513.02 million, an increase of 4.54% compared to the previous year's $490.74 million. Losses were -$68.63 million, -36.72% less than in 2024.